Cargando…
A new questionnaire for assessment of adverse events associated with triptans: methods of assessment influence the results. Preliminary results
Triptans are the treatment of choice for migraine sufferers with disabling attacks. However, the proportion of patients reporting side effects after any acute treatment may vary in regard to the method of assessment. This study was conducted in a neurology office focusing on headache in Italy. We pr...
Autores principales: | Feleppa, Michele, Sheftell, Fred D., Ciannella, Luciana, D’Alessio, Amedeo, Apice, Giancarlo, Capobianco, Nino N., Saracino, Donato M. T., Di Iorio, Walter, Bigal, Marcelo E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3451596/ http://dx.doi.org/10.1007/s10194-004-0123-4 |
Ejemplares similares
-
An integrated approach to cephalalgic patients. Preliminary results on 64 adult patients with migraine without aura
por: Ciannella, Luciana, et al.
Publicado: (2004) -
P300 and contingent negative variation in migraine
por: Feleppa, Michele, et al.
Publicado: (2004) -
Development and validation of a pharmacy migraine questionnaire to assess suitability for treatment with a triptan
por: Diener, Hans-Christoph, et al.
Publicado: (2008) -
Adding acute treatments for patients on triptans: Results of the American Migraine Prevalence & Prevention (AMPP) study
por: Lipton, RB, et al.
Publicado: (2013) -
All triptans are not the same
por: Rapoport, Alan M., et al.
Publicado: (2001)